Published by Benjamin Chiou on 10th June 2024
(Sharecast News) - The share price of AIM-listed Arecor Therapeutics dropped by almost a third on Monday after the biopharma firm warned that its working capital requirements had "accelerated" while full-year revenues remain highly uncertain.
URL: http://www.digitallook.com/dl/news/story/34349608/...